Active, not recruitingPhase 3NCT04888221

Efficacy of Tocilizumab in Association to Steroids in Giant Cell Arteritis With Cerebro-vascular Involvement

Studying Giant cell arteritis

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Assistance Publique - Hôpitaux de Paris
Principal Investigator
Sonia ALAMOWITCH, PU-PH
Assistance Publique - Hôpitaux de Paris
Intervention
Tocilizumab(drug)
Enrollment
66 enrolled
Eligibility
60 years · All sexes
Timeline
20212025

Study locations (1)

Collaborators

Roche Chugai · Roche Pharma AG

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT04888221 on ClinicalTrials.gov

Other trials for Giant cell arteritis

Additional recruiting or active studies for the same condition.

See all trials for Giant cell arteritis

← Back to all trials